Syros Pharmaceuticals, Inc (SYRS) Covered Calls

You can sell covered calls on Syros Pharmaceuticals, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for SYRS (prices last updated Tue 4:16 PM ET):

Syros Pharmaceuticals, Inc (SYRS) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
7.22 -0.34 6.55 7.77 132K -3.0 0.3B
Covered Calls For Syros Pharmaceuticals, Inc (SYRS)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Aug 16 7.5 0.35 7.42 1.1% 16.1%
Sep 20 7.5 0.60 7.17 4.6% 28.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for cancer and monogenic diseases, and building a pipeline of gene control medicines. Its lead product candidates include SY-1425, a selective retinoic acid receptor alpha agonist, which is in a Phase II clinical trial for genomically defined subsets of patients with acute myeloid leukemia (AML) and myelodysplastic syndrome; and SY-1365, a selective CDK7 inhibitor, which is in a Phase I clinical trial that is used for treating patients with solid tumors and blood cancers, including ovarian cancer, breast cancer, and AML. The company was formerly known as LS22, Inc. and changed its name to Syros Pharmaceuticals, Inc. in August 2012. Syros Pharmaceuticals, Inc. was founded in 2011 and is headquartered in Cambridge, Massachusetts